Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel in Children Under Four with Schistosomiasis
NCT03640377Phase 2Completed
- Sponsor
- Rhode Island Hospital
- Start
- Feb 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of praziquantel in schistosomiasis, schistosomiasis mansoni, Schistosoma japonicum infection, sponsored by Rhode Island Hospital. Started Feb 2021; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasisschistosomiasis mansoniSchistosoma japonicum infection
Beyond the preview
Go deeper on NCT03640377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640377.